Article

The Adverse Event Atlas and Signal Consensus Index: A Multi-Source Pharmacovigilance Platform

2026-05-06

Abstract excerpt

<h4>Background</h4> Post-market pharmacovigilance relies predominantly on single-database disproportionality analysis of spontaneous adverse event reports, which lacks corroboration across independent evidence streams and cannot integrate randomised trial evidence. No publicly accessible platform has previously combined European national pharmacovigilance registries, the US FDA Adverse Event Reporting System (FAE...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 73044fe2-1129-5c0f-9014-911094c8a5e6
DOI: 10.64898/2026.05.05.26352239

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Adverse Event Atlas and Signal Consensus Index: A Multi-Source Pharmacovigilance PlatformDOI 10.64898/2026.05.05.26352239Read

Distinct glycaemic safety reporting patterns for alpelisib and capivasertib: a disproportionality analysis of the FAERS databaseSemantic proximity Read

Pharmacovigilance analysis of inclisiran:a real-world assessment based on the FAERS databaseSemantic proximity Read

Adverse event analysis and signal detection of calcitonin gene-related peptide inhibitors using the FDA Adverse Event Reporting System databaseSemantic proximity Read

Safety assessment of S-1: Real-world adverse event analysis from the FAERS databaseSemantic proximity Read

Class-Wide Disproportionate Reporting of Impaired Gastric Emptying Across Nine Glucagon-Like Peptide-1 Receptor Agonist Products: A Signal-Detection Analysis of the FDA Adverse Event Reporting SystemSemantic proximity Read

Reported Drug Spectrum and Disproportionality Signals for Malignant Neoplasm Progression in FAERS: A Real-World Pharmacovigilance StudySemantic proximity Read

Analysis and Mining of Baloxavir Marboxil Adverse Event Signals in Elderly Patients Based on the FAERS DatabaseSemantic proximity Read

Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS DatabaseSemantic proximity Read

A Hybrid Pharmacovigilance Method for National-Scale Comorbidity Discovery: Association Rules with FDA-Approved PRR/Chi-square and EBGM Validation.Semantic proximity Read

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for TivozanibSemantic proximity Read

Analysis and Mining of Baloxavir Marboxil Adverse Event Signals in Elderly Patients Based on the FAERS DatabaseSemantic proximity Read

A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for OsimertinibSemantic proximity Read